Member Info for jdt1990

Speak to Deeks...not AS’s problem. He just has the solution!

Yeah I certainly don’t disagree PL communication has been inconsistent which has caused some of this as opposed to deliberately misleading. I just think the frustration is misdirected around the lft “delay” when the company is still delivering.
Anyone who’s invested in a dog sh*t aim company knows the red flags and can see a cowboy ceo a mile off. I don’t think AS is one.
Hes caught between a rock and a hard place really. Avct prior to COViD just did it all at their own pace.
Company suddenly shone into the spotlight and AS clearly excited and wanted to let shareholders know.
At that point he needed guidance from a professional PR company / advisor. Yellow Jersey weren’t that!
FTI only can on the scene recently and I wonder if they have had more involvement in how the info is fed to investors, a cause for the inconsistency.
For me, it’s a case of the company we’re centre stage overnight and rabbit in the headlights.
Given the tech is clearly working, iis on board (and good ones at that) plus still well in the running for a top class LFT. I can very much forgive that.
I haven’t been diluted since the main raise (which was great business), AVA6000 delivered on time, collaborations, licensing deals, Affimer IP reputation still well in tact.
It’s a classic case of grown quicker than they can deal with in some areas but the key ones are being delivered on.
Some may see otherwise but that’s my two cents on why I am very happy holding here

Agree fully with you sleepydave.
Think a lot here underestimate the task that was actually at hand for a company the size Avct was a year ago.
I we were a GSK for example with thousands of staff globally, infinite money to p*ss up the wall on R&D, could attract best in area staff to employ in droves to solve the problem I would maybe get the moaning.
Don’t get me wrong the timelines stated and missed isn’t great but it needs some wider perspective.
Avct had none of the above at their disposal to deal with a global pandemic that ABSOLUTELY NOBODY had a clue how to deal with. Not to mention the virus mutates so goalposts changed regularly as did scientific opinion that govts etc hung their every move on.
Then you add in the fact we were reliant on third parties. We had to. Some of those incompetent (no names but CONDOR and PD spring to mind)
In doing that, protecting the balance sheet and reputation of a company and its IP that you have worked for years to build up which is still at its heart an oncology therapeutics company.
Just look at the RNSs coming through in the last 4 months. The tech works and it’s generating revenue. That should mean no dilution going forward.
AS has 6m options linked to SP and commercial milestones, he’s aligned to shareholders.
Think people need to cut AS some slack an realise how incredible what this business has achieved in 12 months is - and it could be about to get much much better!

Just to be clear - I don’t think any Medusa / Avct link would be govt related.
I think this has been a really smart move by AS to have a company on board who will provide capacity for Avcts tests outside of any govt contracts.
BBI/ODX and co produce for govt.
Avct have their own partners for production to sell to the world.
Would just make no sense to reduce your capacity for higher margin sales by committing that to govt who want to pay significantly less

Visainn you’re wrong.
Medusa19 have EXCLUSIVE rights to sell the Avct test direct to consumers. Nowhere does it say that stops them selling to entities outside the d2c market. Medusa will be able to sell Avacta tests to anyone. The exclusivity is for direct to consumers. That allows multiple partners on other non d2c fronts.
https://www.lse.co.uk/rns/AVCT/distribution-agreement-for-covid-19-antigen-test-21mboh9bzzm6j5g.html

If that Medusa 50m capacity they claimed was anywhere near true, the fact they slashed the price of their own average performing antibody saliva test suggests it’s not flying off the shelves. I would be very surprised if they are using a large portion of their manufacturing capacity right now.
Could they be a dark horse manufacturing partner for Avct too, AN or even saliva could make a Phoenix like rise from the dead?

AS probably just wants some new investors who don’t clog up his inbox with “are we there yet” “where’s the test” because they’ve promised the wife a landscaped garden in summer!

There is also a chance that AS’s hands have been partially tied as to what he can say.
Talk of him being “manipulative” around news, we still don’t know if anything is covered by a possible govt NDA (of course it may not)
However, don’t forget - AVCT have a nomad and a PR company who I can’t see would let this happen for no good reason.
GRL this week had stated 2 months from a permit date for gold production and their nomad forced an RNS to explain very vaguely why it hadn’t happened. Company wanted to wait a few days.

https://www.google.co.uk/amp/s/uk.news.yahoo.com/amphtml/senegal-malawi-contagious-reluctance-sees-090004771.html
?

Same here - took a pretty significant loss over at SML see that's still in the doldrums....
Any Co where they get taken in by some Ponzi scheme investor I am glad to be out of, learned a lesson there!
Got to kiss plenty of frogs and all that......

Carpenter - they don’t just walk around hospitals swabbing everyone in there for a COViD sample. They have to find enough people at the right range of viral loads who consent to being part of it. As cases drop (which they have been in UK and Spain of late - its global cases increasing) that makes it more difficult.
They want clinical samples and rightly so with the scrutiny the CE marking process is going to come under. Results are more realistic of real world but the cost of that is time.

I think we can probably expect another RNS next week with the full details. Emma said they wanted to wait a couple of days longer but Nomad forced their hand having initially told the market 2 months for gold pour post EP approval

https://www.adeptrix.com/store#!/SARS-CoV-2-S1-Glycoprotein/p/234586062/category=0
Go buy one if you want Gruffell

Boris Johnson 27/08/2020 Oxford, Nanopore, Mologic, Novacyt, OptiGene, LGC, Quantum DX, Avacta, LumiraDX, AstraZeneca Roundtable with science industry on scaling up mass testing

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/958306/Rt-Hon-Boris-Johnson-MP-meetings-July-to-September-2020.csv/preview

SP held up pretty well - shows no real concerns
https://twitter.com/GoldstoneRes/status/1382970509403451397

https://www.linkedin.com/in/joe-fitchett-a1890056?originalSubdomain=uk

Between him and #InColinwetrust very happy to be in AVCT and away from the COViD chancers!

Well hey ho....twice the revenue for Avct and more fool the uk govt. But I could 100% see that being the case sieveco!

Well they have to keep that pantomime lft villain feel in a job somehow right?

I think Ndn won the prize for biggest bell on this bb many moons ago!